Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice

Methamphetamine (MA) is a highly addictive drug, and MA use disorder is often comorbid with anxiety and cognitive impairment. These comorbid conditions are theorized to reflect glutamate-related neurotoxicity within the frontal cortical regions. However, our prior studies of MA-sensitized mice indic...

Full description

Bibliographic Details
Main Authors: Christopher J. E. Denning, Lauren E. Madory, Jessica N. Herbert, Ryan A. Cabrera, Karen K. Szumlinski
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/3/1928
_version_ 1797318636542623744
author Christopher J. E. Denning
Lauren E. Madory
Jessica N. Herbert
Ryan A. Cabrera
Karen K. Szumlinski
author_facet Christopher J. E. Denning
Lauren E. Madory
Jessica N. Herbert
Ryan A. Cabrera
Karen K. Szumlinski
author_sort Christopher J. E. Denning
collection DOAJ
description Methamphetamine (MA) is a highly addictive drug, and MA use disorder is often comorbid with anxiety and cognitive impairment. These comorbid conditions are theorized to reflect glutamate-related neurotoxicity within the frontal cortical regions. However, our prior studies of MA-sensitized mice indicate that subchronic, behaviorally non-contingent MA treatment is sufficient to dysregulate glutamate transmission in mouse brain. Here, we extend this prior work to a mouse model of high-dose oral MA self-administration (0.8, 1.6, or 3.2 g/L; 1 h sessions × 7 days) and show that while female C57BL/6J mice consumed more MA than males, MA-experienced mice of both sexes exhibited some signs of anxiety-like behavior in a behavioral test battery, although not all effects were concentration-dependent. No MA effects were detected for our measures of visually cued spatial navigation, spatial learning, or memory in the Morris water maze; however, females with a history of 3.2 g/L MA exhibited reversal-learning deficits in this task, and mice with a history of 1.6 g/L MA committed more working-memory incorrect errors and relied upon a non-spatial navigation strategy during the radial-arm maze testing. Relative to naïve controls, MA-experienced mice exhibited several changes in the expression of certain glutamate receptor-related proteins and their downstream effectors within the ventral and dorsal areas of the prefrontal cortex, the hippocampus, and the amygdala, many of which were sex-selective. Systemic pretreatment with the mGlu1-negative allosteric modulator JNJ 162596858 reversed the anxiety-like behavior expressed by MA-experienced mice in the marble-burying test, while systemic pretreatment with NMDA or the NMDA antagonist MK-801 bi-directionally affected the MA-induced reversal-learning deficit. Taken together, these data indicate that a relatively brief history of oral MA is sufficient to induce some signs of anxiety-like behavior and cognitive dysfunction during early withdrawal that reflect, at least in part, MA-induced changes in the corticolimbic expression of certain glutamate receptor subtypes of potential relevance to treating symptoms of MA use disorder.
first_indexed 2024-03-08T03:55:13Z
format Article
id doaj.art-fffe02464e334e46a4a58fae725ee58c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T03:55:13Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-fffe02464e334e46a4a58fae725ee58c2024-02-09T15:15:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-02-01253192810.3390/ijms25031928Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in MiceChristopher J. E. Denning0Lauren E. Madory1Jessica N. Herbert2Ryan A. Cabrera3Karen K. Szumlinski4Department of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USADepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USADepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USADepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USADepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USAMethamphetamine (MA) is a highly addictive drug, and MA use disorder is often comorbid with anxiety and cognitive impairment. These comorbid conditions are theorized to reflect glutamate-related neurotoxicity within the frontal cortical regions. However, our prior studies of MA-sensitized mice indicate that subchronic, behaviorally non-contingent MA treatment is sufficient to dysregulate glutamate transmission in mouse brain. Here, we extend this prior work to a mouse model of high-dose oral MA self-administration (0.8, 1.6, or 3.2 g/L; 1 h sessions × 7 days) and show that while female C57BL/6J mice consumed more MA than males, MA-experienced mice of both sexes exhibited some signs of anxiety-like behavior in a behavioral test battery, although not all effects were concentration-dependent. No MA effects were detected for our measures of visually cued spatial navigation, spatial learning, or memory in the Morris water maze; however, females with a history of 3.2 g/L MA exhibited reversal-learning deficits in this task, and mice with a history of 1.6 g/L MA committed more working-memory incorrect errors and relied upon a non-spatial navigation strategy during the radial-arm maze testing. Relative to naïve controls, MA-experienced mice exhibited several changes in the expression of certain glutamate receptor-related proteins and their downstream effectors within the ventral and dorsal areas of the prefrontal cortex, the hippocampus, and the amygdala, many of which were sex-selective. Systemic pretreatment with the mGlu1-negative allosteric modulator JNJ 162596858 reversed the anxiety-like behavior expressed by MA-experienced mice in the marble-burying test, while systemic pretreatment with NMDA or the NMDA antagonist MK-801 bi-directionally affected the MA-induced reversal-learning deficit. Taken together, these data indicate that a relatively brief history of oral MA is sufficient to induce some signs of anxiety-like behavior and cognitive dysfunction during early withdrawal that reflect, at least in part, MA-induced changes in the corticolimbic expression of certain glutamate receptor subtypes of potential relevance to treating symptoms of MA use disorder.https://www.mdpi.com/1422-0067/25/3/1928NMDA receptorGroup 1 mGluRanxietysex differencesspatial learningworking memory
spellingShingle Christopher J. E. Denning
Lauren E. Madory
Jessica N. Herbert
Ryan A. Cabrera
Karen K. Szumlinski
Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
International Journal of Molecular Sciences
NMDA receptor
Group 1 mGluR
anxiety
sex differences
spatial learning
working memory
title Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
title_full Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
title_fullStr Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
title_full_unstemmed Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
title_short Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice
title_sort neuropharmacological evidence implicating drug induced glutamate receptor dysfunction in affective and cognitive sequelae of subchronic methamphetamine self administration in mice
topic NMDA receptor
Group 1 mGluR
anxiety
sex differences
spatial learning
working memory
url https://www.mdpi.com/1422-0067/25/3/1928
work_keys_str_mv AT christopherjedenning neuropharmacologicalevidenceimplicatingdruginducedglutamatereceptordysfunctioninaffectiveandcognitivesequelaeofsubchronicmethamphetamineselfadministrationinmice
AT laurenemadory neuropharmacologicalevidenceimplicatingdruginducedglutamatereceptordysfunctioninaffectiveandcognitivesequelaeofsubchronicmethamphetamineselfadministrationinmice
AT jessicanherbert neuropharmacologicalevidenceimplicatingdruginducedglutamatereceptordysfunctioninaffectiveandcognitivesequelaeofsubchronicmethamphetamineselfadministrationinmice
AT ryanacabrera neuropharmacologicalevidenceimplicatingdruginducedglutamatereceptordysfunctioninaffectiveandcognitivesequelaeofsubchronicmethamphetamineselfadministrationinmice
AT karenkszumlinski neuropharmacologicalevidenceimplicatingdruginducedglutamatereceptordysfunctioninaffectiveandcognitivesequelaeofsubchronicmethamphetamineselfadministrationinmice